Financial Markets Blog
-
Markets Rally on Iran War Exit Hopes as Eli Lilly Scores Major FDA Win – April 1, 2026
U.S. stocks rallied on April 1, 2026, with the NASDAQ gaining 1.24% as speculation grows about an end to the Iran conflict while Eli Lilly secures FDA approval for its groundbreaking obesity pill.
-
Markets Surge on Iran War ‘Off-Ramp’ Hopes: Daily Briefing for March 31, 2026
Wall Street rallies nearly 3% as diplomatic signals hint at potential Iran war de-escalation, while earnings deliver mixed results highlighted by stunning beats from OMER and SNX.
-
Markets Stumble as Iran Conflict Escalates: Your Daily Briefing for March 30, 2026
U.S. markets declined Monday as the escalating Iran conflict disrupted supply chains and sent investors seeking safety, with the NASDAQ falling 0.76% while the Dow eked out modest gains.
-
Markets Plunge as Middle East Crisis Deepens: Dow Enters Correction Territory on March 27, 2026
Wall Street suffers steep losses as the Dow enters correction territory amid escalating U.S.-Iran tensions, with the NASDAQ posting its worst weekly decline in nearly a year.
-
Markets Tumble as Iran Tensions Dominate Headlines: Daily Briefing for March 26, 2026
Markets plunged Thursday with the NASDAQ down 2.39% as Iran crisis headlines, memory chip weakness, and mixed earnings weighed heavily on investor sentiment.
-
Markets Climb Despite Iran War Jitters; SpaceX IPO Buzz Lifts Space Stocks – March 25, 2026
U.S. markets climbed on Wednesday as SpaceX IPO rumors sparked enthusiasm, even as the Iran war continues to pressure energy prices and reshape the economic outlook.
Got any book recommendations?